• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎病毒患者中谷丙转氨酶(ALT)酶活性的临床意义。

Clinical significance of activity of ALT enzyme in patients with hepatitis C virus.

作者信息

Akkaya Onder, Kiyici Murat, Yilmaz Yusuf, Ulukaya Engin, Yerci Omer

机构信息

Department of Internal Medicine, Uludag University Medical School, Bursa, Turkey.

出版信息

World J Gastroenterol. 2007 Nov 7;13(41):5481-5. doi: 10.3748/wjg.v13.i41.5481.

DOI:10.3748/wjg.v13.i41.5481
PMID:17907292
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4171283/
Abstract

AIM

To investigate serum alanine aminotransferase (ALT) levels in relation to the clinical, biochemical, ultrasonographic and histological characteristics of patients with hepatitis C virus.

METHODS

Duration of disease, HCV-RNA, liver steatosis, and the hepatitis activity index (HAI) were correlated with serum ALT in 36 patients with HCV. ALT values were also investigated in 16 control subjects without any liver diseases.

RESULTS

In bivariate analyses, ALT levels correlated with duration of HCV infection (P < 0.01), HCV-RNA (P < 0.05), and the HAI (P < 0.01). Among the components of the HAI, ALT concentrations were significantly associated with periportal bridging/necrosis (P < 0.01) and fibrosis (P < 0.05). In multivariate analysis, periportal bridging/necrosis (beta = 0.508; P < 0.01), duration of HCV infection (beta = 0.413; P < 0.01), and HCV-RNA (beta = 0.253; P < 0.05) were independently associated with ALT activity. The normal ALT activity for men and women was < 23 IU/L and < 22 IU/L, respectively.

CONCLUSION

In patients with HCV, alterations in the liver tissue as reflected by ALT elevation are mainly associated with periportal bridging/necrosis, viral load and duration of disease. A cut-off value < 23 IU/L distinguished with high diagnostic accuracy healthy controls from patients with HCV.

摘要

目的

研究丙型肝炎病毒患者血清丙氨酸氨基转移酶(ALT)水平与临床、生化、超声及组织学特征之间的关系。

方法

对36例丙型肝炎病毒患者的病程、HCV-RNA、肝脏脂肪变性及肝炎活动指数(HAI)与血清ALT进行相关性分析。同时对16例无任何肝脏疾病的对照受试者的ALT值进行了研究。

结果

在双变量分析中,ALT水平与HCV感染持续时间(P < 0.01)、HCV-RNA(P < 0.05)及HAI(P < 0.01)相关。在HAI的各组成部分中,ALT浓度与汇管区桥接/坏死(P < 0.01)及纤维化(P < 0.05)显著相关。多变量分析显示,汇管区桥接/坏死(β = 0.508;P < 0.01)、HCV感染持续时间(β = 0.413;P < 0.01)及HCV-RNA(β = 0.253;P < 0.05)与ALT活性独立相关。男性和女性的正常ALT活性分别< 23 IU/L和< 22 IU/L。

结论

在丙型肝炎病毒患者中,ALT升高所反映的肝组织改变主要与汇管区桥接/坏死、病毒载量及病程有关。< 23 IU/L的临界值能以较高的诊断准确性区分健康对照与丙型肝炎病毒患者。

相似文献

1
Clinical significance of activity of ALT enzyme in patients with hepatitis C virus.丙型肝炎病毒患者中谷丙转氨酶(ALT)酶活性的临床意义。
World J Gastroenterol. 2007 Nov 7;13(41):5481-5. doi: 10.3748/wjg.v13.i41.5481.
2
Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C.慢性丙型肝炎患者肝脏组织学、谷丙转氨酶升高及丙型肝炎病毒核糖核酸滴度的评估
Am J Gastroenterol. 1996 Aug;91(8):1516-22.
3
AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C.丙型肝炎患者中,谷草转氨酶/谷丙转氨酶比值≥1并不能诊断为肝硬化。
Dig Dis Sci. 1998 Sep;43(9):2156-9. doi: 10.1023/a:1018888021118.
4
Incidentally detected asymptomatic hepatitis C virus infection with significant fibrosis: Possible impacts on management.偶然检测到的无症状丙型肝炎病毒感染伴显著纤维化:对管理的可能影响。
Indian J Pathol Microbiol. 2018 Jul-Sep;61(3):345-349. doi: 10.4103/IJPM.IJPM_240_17.
5
Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan.台湾慢性丙型肝炎患者血清转氨酶水平、肝脏组织学与病毒学状态之间的关系
J Gastroenterol Hepatol. 1998 Jul;13(7):685-90. doi: 10.1111/j.1440-1746.1998.tb00714.x.
6
[Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].[丙氨酸转氨酶筛查在献血者中对降低血液疗法传播乙型和丙型肝炎风险的意义]
Vnitr Lek. 2016 Jan;62(1):9-16.
7
Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.慢性丙型肝炎3a型患者生化标志物及HCV RNA滴度与纤维化分期和分级的相关性
Eur J Gastroenterol Hepatol. 2014 Jul;26(7):788-94. doi: 10.1097/MEG.0000000000000109.
8
High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied.如果采用修正后的ALT正常范围,高ALT水平可预测抗HCV阳性血液透析患者的病毒血症。
Clin Nephrol. 2000 Aug;54(2):151-6.
9
Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.确定接受血液透析患者血清丙氨酸氨基转移酶的临界值,以识别丙型肝炎病毒血症患者的生化活性。
J Clin Virol. 2006 Mar;35(3):298-302. doi: 10.1016/j.jcv.2005.09.010. Epub 2005 Nov 11.
10
Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.慢性肾衰竭患者血清转氨酶活性降低:对病毒性肝炎检测的影响
Am J Kidney Dis. 2001 Nov;38(5):1009-15. doi: 10.1053/ajkd.2001.28590.

引用本文的文献

1
Contemporary Insights into Hepatitis C Virus: A Comprehensive Review.丙型肝炎病毒的当代见解:全面综述
Microorganisms. 2024 May 21;12(6):1035. doi: 10.3390/microorganisms12061035.
2
Latest insights into the epidemiology, characteristics, and therapeutic strategies of chronic hepatitis B patients in indeterminate phase.慢性乙型肝炎不确定期患者的流行病学、特征和治疗策略的最新见解。
Eur J Med Res. 2024 Jun 21;29(1):343. doi: 10.1186/s40001-024-01942-0.
3
Hepatitis C virus antibody seropositivity is associated with albuminuria but not peripheral artery disease in patients with type 2 diabetes.丙型肝炎病毒抗体血清阳性与白蛋白尿有关,但与 2 型糖尿病患者的外周动脉疾病无关。
Sci Rep. 2024 Feb 26;14(1):4607. doi: 10.1038/s41598-024-55352-7.
4
Self-awareness of hepatitis C infection in the United States: A cross-sectional study based on the National Health Nutrition and Examination Survey.美国丙型肝炎感染的自我意识:基于全国健康营养与体检调查的横断面研究。
PLoS One. 2023 Oct 24;18(10):e0293315. doi: 10.1371/journal.pone.0293315. eCollection 2023.
5
Prediction of Hepatitis disease using ensemble learning methods.基于集成学习方法的肝炎预测。
J Prev Med Hyg. 2022 Oct 27;63(3):E424-E428. doi: 10.15167/2421-4248/jpmh2022.63.3.2515. eCollection 2022.
6
Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older.在 75 岁或以上的日本丙型肝炎病毒感染患者中,glecaprevir 和 pibrentasvir 的疗效和安全性。
BMC Gastroenterol. 2022 Apr 28;22(1):210. doi: 10.1186/s12876-022-02284-z.
7
Iron Pathways and Iron Chelation Approaches in Viral, Microbial, and Fungal Infections.病毒、微生物和真菌感染中的铁代谢途径及铁螯合方法
Pharmaceuticals (Basel). 2020 Sep 25;13(10):275. doi: 10.3390/ph13100275.
8
An update on hepatitis C virus genotype distribution in Jordan: a 12-year retrospective study from a tertiary care teaching hospital in Amman.约旦丙型肝炎病毒基因型分布的最新情况:安曼一家三级保健教学医院的 12 年回顾性研究。
BMC Infect Dis. 2019 Dec 31;20(1):3. doi: 10.1186/s12879-019-4735-3.
9
Seroepidemiology and risk factors of hepatitis C virus infection in East Azerbaijan, Iran: a population-based Azar Cohort study.伊朗东阿塞拜疆省丙型肝炎病毒感染的血清流行病学及危险因素:一项基于人群的阿扎尔队列研究
Caspian J Intern Med. 2019 Summer;10(3):326-331. doi: 10.22088/cjim.10.3.326.
10
Redefining the Normal Values of Serum Aminotransferases in Healthy Indian Males.重新定义健康印度男性血清转氨酶的正常参考值
J Clin Exp Hepatol. 2019 Mar-Apr;9(2):191-199. doi: 10.1016/j.jceh.2018.06.003. Epub 2018 Jun 21.

本文引用的文献

1
Hepatitis C virus: virology, diagnosis and management of antiviral therapy.丙型肝炎病毒:病毒学、抗病毒治疗的诊断与管理
World J Gastroenterol. 2007 May 7;13(17):2461-6. doi: 10.3748/wjg.v13.i17.2461.
2
Biochemical and virologic parameters in patients co-infected with hepatitis C and HIV versus patients with hepatitis C mono-infection.丙型肝炎和艾滋病毒合并感染患者与丙型肝炎单一感染患者的生化和病毒学参数。
Am J Med Sci. 2007 May;333(5):271-5. doi: 10.1097/MAJ.0b013e31805341f0.
3
Serum gamma-glutamyltransferase, alanine aminotransferase, and aspartate aminotransferase activity in Iranian healthy blood donor men.伊朗健康男性献血者的血清γ-谷氨酰转移酶、丙氨酸氨基转移酶和天冬氨酸氨基转移酶活性
World J Gastroenterol. 2007 Feb 14;13(6):889-94. doi: 10.3748/wjg.v13.i6.889.
4
Histological and nonhistological criteria in the evaluation of liver involvement in chronic hepatitis C.
Rom J Intern Med. 2006;44(2):117-30.
5
Hepatitis C virus: virology and experimental systems.
Clin Liver Dis. 2006 Nov;10(4):773-91. doi: 10.1016/j.cld.2006.08.018.
6
Chronic hepatitis C and screening for hepatocellular carcinoma.慢性丙型肝炎与肝细胞癌筛查
Clin Liver Dis. 2006 Nov;10(4):735-52. doi: 10.1016/j.cld.2006.08.010.
7
Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years.丙型肝炎病毒携带者,谷丙转氨酶水平持续正常:生物学特性及10年肝病自然史的更新情况
J Viral Hepat. 2006 May;13(5):290-6. doi: 10.1111/j.1365-2893.2005.00667.x.
8
Chronic hepatitis C in patients with persistently normal alanine transaminase levels.丙氨酸转氨酶水平持续正常的患者中的慢性丙型肝炎
Clin Gastroenterol Hepatol. 2006 May;4(5):645-52. doi: 10.1016/j.cgh.2006.02.002.
9
Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study.在一项大规模人群研究中对血清丙氨酸氨基转移酶正常上限及其调节因素的重新评估。
Liver Int. 2006 May;26(4):445-50. doi: 10.1111/j.1478-3231.2006.01197.x.
10
Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease.丙型肝炎病毒血清学和病毒学检测以及丙型肝炎病毒相关肝病的临床诊断
Int J Med Sci. 2006;3(2):35-40. doi: 10.7150/ijms.3.35. Epub 2006 Apr 1.